comparemela.com

Bill Shingleton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

05 12 22 -- Your New EU IDMP Implementation Strategy

02 22 22 -- 5 Best Practices Of Data Management For Emerging Biotechs

Overcoming Cell Therapy Supply Chain Challenges

Overcoming Cell Therapy Supply Chain Challenges By Bill Shingleton, Cell and Gene Therapy Biology Director, Cytiva Patient cells are the foundations for cell and gene therapies, products that are increasing in quantity and in their diverse treatment applications. However, cell and gene therapy supply chains introduce specific challenges that differ from those associated with biologics. The development, manufacturing, and transport of cell and gene therapies require consideration and care, including temperature controls and tracking and verifying the chain of custody. Collaborative efforts and automated solutions will be critical to help lead the changes to produce cell and gene therapies to meet market and patient demand. This will allow the industry to take a step back from the reliance on manual and time-consuming laboratory-based methods.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.